melanotan-ii has been researched along with bremelanotide in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmad Fuaad, A; Bauer, U; Cai, M; Cheneval, O; Craik, DJ; Cromm, PM; Daly, NL; Dellsén, A; Durek, T; Harvey, PJ; Hruby, VJ; Kaas, Q; Kessler, H; Knerr, L; Larsson, N; Österlund, T; Plowright, AT; Schroeder, CI; Weidmann, J; White, AM; Zhou, Y | 1 |
| Bauer, U; Cheneval, O; Craik, DJ; de Veer, SJ; Dellsén, A; Durek, T; Fuaad, AA; Kaas, Q; Knerr, L; Larsson, N; Österlund, T; Plowright, AT; Schroeder, CI; Weidmann, J; White, AM | 1 |
| Craik, DJ; Dellsén, A; Durek, T; Jansen, F; Kaas, Q; Knerr, L; Larsson, N; Plowright, AT; White, AM | 1 |
| Frison, G; Mestria, S; Odoardi, S; Strano Rossi, S | 1 |
4 other study(ies) available for melanotan-ii and bremelanotide
| Article | Year |
|---|---|
Development of Novel Melanocortin Receptor Agonists Based on the Cyclic Peptide Framework of Sunflower Trypsin Inhibitor-1.
Topics: Drug Design; HEK293 Cells; Helianthus; Humans; Methylation; Molecular Structure; Peptides, Cyclic; Receptor, Melanocortin, Type 1; Receptor, Melanocortin, Type 3; Structure-Activity Relationship | 2018 |
Melanocortin 1 Receptor Agonists Based on a Bivalent, Bicyclic Peptide Framework.
Topics: Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Peptides, Cyclic; Receptor, Melanocortin, Type 1; Structure-Activity Relationship | 2021 |
Late-Stage Functionalization with Cysteine Staples Generates Potent and Selective Melanocortin Receptor-1 Agonists.
Topics: Cysteine; Melanocortins; Peptides; Pyridazines; Receptor, Melanocortin, Type 1; Receptor, Melanocortin, Type 3; Receptor, Melanocortin, Type 4; Receptors, Melanocortin; Structure-Activity Relationship; Xylenes | 2022 |
LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs.
Topics: alpha-MSH; Chromatography, Liquid; Humans; Mass Spectrometry; Peptides, Cyclic; Performance-Enhancing Substances | 2021 |